首页> 外文期刊>International journal of colorectal disease. >Doppler-guided haemorrhoidal artery ligation with recto anal repair: a new technique for the treatment of symptomatic haemorrhoids.
【24h】

Doppler-guided haemorrhoidal artery ligation with recto anal repair: a new technique for the treatment of symptomatic haemorrhoids.

机译:多普勒引导的肛门直肠结直肠修复术:这是一种新技术,可用于治疗有症状的痔疮。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Doppler-guided haemorrhoidal artery ligation (DGHAL) is a minimally invasive surgical technique used to treat symptomatic haemorrhoids. In 2005, the DGHAL proctoscope was redesigned to incorporate a window through which a recto anal repair (RAR) could be performed to improve the outcome in patients with significant prolapse symptoms. The aim of this study was to observe the outcome of a series of consecutive DGHAL-RAR procedures. METHOD: Seventy-seven consecutive patients (49 male) underwent DGHAL-RAR for symptomatic haemorrhoids and were reviewed for a minimum of 6 months post-surgery. RESULTS: Fifty-seven (74%) of patients presented with both prolapse and bleeding symptoms. The median number of DGHALs performed was six, and the median number of RARs was two. Most (96%) patients were discharged the same day. At follow-up, 11 patients complained of recurrent symptoms, five of prolapse, four of bleeding and two of pruritus. Eight patients suffered with post-operative anal fissures. The procedure is recommended by 84.4% of patients 6 weeks post-surgery. CONCLUSION: DGHAL-RAR is safe, effective and well tolerated. It reduces the need for potentially dangerous excisional procedures. The RAR component is an effective addition to DGHAL in the short term for the treatment of prolapse, but longer follow-up will be required to demonstrate durability of the technique.
机译:目的:多普勒引导的痔疮动脉结扎术(DGHAL)是一种微创手术技术,用于治疗有症状的痔疮。 2005年,对DGHAL直肠镜进行了重新设计,以合并一个窗口,通过该窗口可以进行直肠肛门修复(RAR),以改善有严重脱垂症状的患者的预后。这项研究的目的是观察一系列连续DGHAL-RAR程序的结果。方法:连续77例患者(49例男性)因有症状的痔疮而接受了DGHAL-RAR治疗,并且在术后至少6个月接受了检查。结果:五十七(74%)名患者同时出现脱垂和出血症状。执行的DGHAL的中位数为6,而RAR的中位数为2。大多数(96%)患者在同一天出院。随访时,有11例患者主诉复发症状,5例脱垂,4例出血和2例瘙痒。八例术后肛门裂。术后6周的患者中有84.4%的患者建议使用该程序。结论:DGHAL-RAR安全,有效且耐受性良好。它减少了潜在危险的切除程序的需要。在短期内,RAR成分是DGHAL的有效补充,可用于治疗脱垂,但需要更长的随访时间才能证明该技术的持久性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号